Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Scholar Rock Holding Corp
(NQ:
SRRK
)
9.390
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 31, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Scholar Rock Holding Corp
< Previous
1
2
3
4
Next >
Scholar Rock to Present at the 2021 Wedbush PacGrow Healthcare Conference
August 05, 2021
From
Scholar Rock
Via
Business Wire
Scholar Rock Announces Leadership Change
August 03, 2021
From
Scholar Rock
Via
Business Wire
Scholar Rock to Present Apitegromab TOPAZ Phase 2 Trial Results Highlighting Pharmacokinetic (PK) and Pharmacodynamic (PD) Data at the 2021 European Academy of Neurology Congress
June 18, 2021
From
Scholar Rock
Via
Business Wire
Scholar Rock Presents TOPAZ Phase 2 Data Showing the Transformative Potential of Apitegromab in Patients with Type 2 and 3 Spinal Muscular Atrophy (SMA) at the 2021 Virtual SMA Research & Clinical Care Meeting
June 11, 2021
From
Scholar Rock
Via
Business Wire
Scholar Rock to Present Apitegromab Clinical Data from the TOPAZ Phase 2 Trial in Patients with Type 2 and 3 Spinal Muscular Atrophy at the 2021 Virtual SMA Research & Clinical Care Meeting
June 07, 2021
From
Scholar Rock
Via
Business Wire
Scholar Rock to Present at Upcoming Healthcare Conferences in June
May 27, 2021
From
Scholar Rock
Via
Business Wire
Scholar Rock Receives Fast Track Designation from the U.S. FDA for Apitegromab for the Treatment of Patients with Spinal Muscular Atrophy
May 24, 2021
From
Scholar Rock
Via
Business Wire
Scholar Rock to Present Trials in Progress Poster for SRK-181 DRAGON Phase 1 Clinical Trial at the American Society of Clinical Oncology Annual Meeting
May 19, 2021
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports First Quarter 2021 Financial Results and Highlights Business Progress
May 13, 2021
From
Scholar Rock
Via
Business Wire
Scholar Rock Announces Publication of Phase 1 Clinical Trial Data Evaluating Apitegromab in Healthy Volunteers in the Journal Advances in Therapy
May 11, 2021
From
Scholar Rock
Via
Business Wire
Scholar Rock Announces Issuance of U.S. Patent Broadly Relevant to Inhibitors of Myostatin Activation
April 26, 2021
From
Scholar Rock, Inc.
Via
Business Wire
Scholar Rock Presents Biomarker Strategy to Support the SRK-181 DRAGON Phase 1 Proof-of-Concept Trial at the American Association for Cancer Research Annual Meeting
April 10, 2021
From
Scholar Rock, Inc.
Via
Business Wire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.